ARCHIVES

Ax Falls; Recision Asked Of $17 Million For NCI This Year, $42.7 Million Cut In FY 1981 Budget

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

In Brief: Nurses Association Endorses Clinton-Gore; Levin Heads New Society For Neuro-Oncology

June 28, 1996

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

OD Contract Concepts Okayed

October 17, 1986

NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization

June 22, 1990

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990